In the present seroepidemiological study, we showed that only 4% of the ovarian cancers in Norway were due to BRCA1 mutations (1675delA, 1135insA, 816delGT and 3347delAG), and none of the borderline tumours. This evidence concerns the gene BRCA1 and ovarian cancer.